In addition, consistent with in vitro findings, miR-133a showed no difference in cleaved caspase 3 (CC3) by immunohistochemistry staining versus control DDLPS cells (Fig. 4b), which confirmed that loss of miR-133a does not mediate tumor cell growth or survival. The gene discussed is CASP3; the disease is neoplasm.